Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Antibody Contract Manufacturing Global Market Report 2025
Request Sample Buy Now
Global Antibody Contract Manufacturing Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Antibody Contract Manufacturing Global Market Report 2025

By Product (Monoclonal Antibodies, Polyclonal Antibodies, Other Products), By Source (Mammalian, Microbial, Scale Of Operation (Preclinical, Clinical, Commercial), By End-User (Biopharmaceutical Companies, Research Laboratories, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Antibody Contract Manufacturing Market Overview

• Antibody Contract Manufacturing market size has reached to $14.8 billion in 2024

• Expected to grow to $29.79 billion in 2029 at a compound annual growth rate (CAGR) of 15.4%

• Growth Driver: Surge In Clinical Trials Fuels The Antibody Contract Manufacturing Market Growth

• Market Trend: Innovative Single-Use Technology Enhances Antibody-Drug Conjugate Manufacturing Efficiency

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Antibody Contract Manufacturing Market?

Antibody contract manufacturing refers to outsourcing the production and manufacturing of antibodies to specialized contract manufacturing organizations (CMOs). These CMOs are equipped with the expertise, infrastructure, and resources necessary to manufacture antibodies on behalf of pharmaceutical and biotechnology companies.

The main products of antibody contract manufacturing are monoclonal antibodies, polyclonal antibodies, and others. Monoclonal antibodies (mAbs) are antibodies that are designed to target a specific antigen, and antibody contract manufacturing plays a significant role in producing monoclonal antibodies at a large scale, ensuring consistent quality and quantity for therapeutic or diagnostic applications. They are developed from sources such as mammals and microbes at preclinical, clinical, and commercial scales of operation that are used by end users such as biopharmaceutical companies, research laboratories, and others.

Antibody Contract Manufacturing Market Size and growth rate 2025 to 2029: Graph

What Is The Antibody Contract Manufacturing Market Size 2025 And Growth Rate?

The antibody contract manufacturing market size has grown rapidly in recent years. It will grow from $14.8 billion in 2024 to $16.79 billion in 2025 at a compound annual growth rate (CAGR) of 13.4%. The growth in the historic period can be attributed to increased demand for monoclonal antibodies, shift towards personalized medicine, cost optimization, stringent regulatory requirements, globalization of biologics

What Is The Antibody Contract Manufacturing Market Growth Forecast?

The antibody contract manufacturing market size is expected to see rapid growth in the next few years. It will grow to $29.79 billion in 2029 at a compound annual growth rate (CAGR) of 15.4%. The growth in the forecast period can be attributed to increasing r&d spending, expansion of bispecific and multispecific antibodies, rise of antibody-drug conjugates (adcs), increasing healthcare infrastructure, growing government initiatives. Major trends in the forecast period include digitalization and data analytics, advanced upstream technologies, novel downstream processing techniques, sustainability initiatives, contract development and manufacturing integration (CDMO).

The forecast of 15.4% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. biologics market by increasing the cost of single-use bioreactors and chromatography systems sourced from Switzerland and Ireland, thereby slowing antibody therapy development and elevating Contract Development and Manufacturing Organization(CDMO) operational costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Antibody Contract Manufacturing Market Segmented?

1) By Product: Monoclonal Antibodies, Polyclonal Antibodies, Other Products

2) By Source: Mammalian, Microbial

3) Scale Of Operation: Preclinical, Clinical, Commercial

4) By End-User: Biopharmaceutical Companies, Research Laboratories, Other End Users

Subsegments:

1) By Monoclonal Antibodies: Therapeutic Monoclonal Antibodies, Diagnostic Monoclonal Antibodies

2) By Polyclonal Antibodies: Research Polyclonal Antibodies, Therapeutic Polyclonal Antibodies

3) By Other Products: Bispecific Antibodies, Antibody-Drug Conjugates (ADCs), Fusion Proteins

What Is Driving The Antibody Contract Manufacturing Market? Surge In Clinical Trials Fuels The Antibody Contract Manufacturing Market Growth

The rising number of clinical trials is expected to propel the growth of the antibody contract manufacturing market going forward. Clinical trials are research studies conducted with human participants to evaluate the safety and effectiveness of new medical treatments, interventions, or diagnostic procedures. The number of clinical trials involving antibody-based therapeutics or diagnostics expands, for high-quality antibodies, ensuring a timely and compliant supply for clinical trials. For instance, in May 2023, according to ClinicalTrials.gov, a part of the National Institutes of Health (NIH), a US-based government agency responsible for conducting and supporting medical research, in all 50 states of the United States and 221 countries, the number of registered clinical trials studies climbed from 399,499 in 2022 to 437,533 in 2023. Additionally, around 241,498 studies, or 53% of the total, were registered outside the United States, compared to 140,492 studies (31%) registered just in the United States. Therefore, the rising number of clinical trials is driving the growth of the antibody contract manufacturing industry.

What Is Driving The Antibody Contract Manufacturing Market? Rising Prevalence Of Chronic Diseases Accelerates The Growth Of Antibody Contract Manufacturing Market

The increasing prevalence of chronic diseases is expected to propel the growth of the antibody contract manufacturing market going forward. Chronic diseases are long-term medical conditions characterized by their persistent and often progressive nature. Antibody contract manufacturing plays a crucial role in producing therapeutic antibodies used to treat chronic diseases. These antibodies are designed to target specific proteins or cells associated with chronic conditions, providing targeted and personalized treatment. For instance, in January 2022, according to the National Center for Biotechnology Information (NCBI), a US-based scientific research organization, the U.S. population aged 50 and above is projected to surge by 61.11%, growing from 137.25 million in 2020 to reach 221.13 million by 2050. Furthermore, the portion of the population aged 50 and above, affected by at least one chronic disease, is expected to nearly double, rising from 71.522 million in 2020 to an estimated 142.66 million by 2050, representing a 99.5% increase. Therefore, the increasing prevalence of chronic diseases is driving the growth of the antibody contract manufacturing industry.

Who Are The Major Players In The Global Antibody Contract Manufacturing Market?

Major companies operating in the antibody contract manufacturing market include AbbVie Inc., Thermo Fisher Scientific Inc., Boehringer Ingelheim Biopharmaceuticals GmbH, Fujifilm Holdings Corporation, Eurofins Scientific SE, Lonza Group AG, Labcorp Drug Development, Catalent Inc., Charles River Laboratories International Inc., Merck KGaA, Samsung Biologics Co. Ltd., Wuxi Biologics Cayman Inc, Siegfried Holding AG, Recipharm AB, Emergent BioSolutions Inc., Aenova Group, Cambrex Corporation, Aldevron LLC, Novasep Holding SAS, Synthon, KBI Biopharma Inc., Nitto Avecia Pharma Services Inc., Cytovance Biologics Inc., AGC Biologics S.p.A.

What Are The Key Trends Of The Global Antibody Contract Manufacturing Market? Innovative Single-Use Technology Enhances Antibody-Drug Conjugate Manufacturing Efficiency

Major companies operating in the antibody contract manufacturing market are focusing on developing innovation, such as single-use technology that minimizes cross-contamination risks and reduces operational costs. Single-use technology (SUT) refers to disposable components and systems used in biopharmaceutical manufacturing processes. For instance, in September 2024, Merck & Co., a US-based pharmaceutical company, launched the Mobius ADC Reactor designed to enhance the manufacturing of antibody-drug conjugates. A new single-use reactor specifically designed for antibody drug conjugate manufacturing significantly enhances production efficiency by 70% compared to traditional stainless steel or glass methods. Its single-use design minimizes cross-contamination risks and operational costs, allowing for faster turnaround times. Additionally, advanced film technology improves bag strength and leak resistance, ensuring the integrity of highly potent active pharmaceutical ingredients. This innovation supports biopharmaceutical companies in producing critical therapies more safely and efficiently.

What Are The Key Trends Of The Global Antibody Contract Manufacturing Market? Bispecific Antibody Platforms Revolutionize The Antibody Contract Manufacturing Market Dynamics

Major companies operating in the antibody contract manufacturing market are focused on developing innovative solutions such as bispecific antibody platforms. A bispecific antibody platform refers to a technology or methodology used in the development of bispecific antibodies. The bispecific antibody platform encompasses the scientific and technological approaches used to create these specialized antibodies. For instance, in September 2022, Samsung Biologics, a South Korea-based contract development and manufacturing organization (CDMO) announced the launch of ‘S-DUAL’ and ‘DEVELOPICK’. S-DUAL platform stands out as a high-yield bispecific antibody platform, boasting an impressive 99% success rate in chain pairing. Its distinctive asymmetrical structure serves to mitigate risks related to chemistry, manufacturing, and control (CMC). It ensures strong binding affinity among chains and achieves elevated titer and purity, optimizing ease of manufacturing. DEVELOPICK is a swift assessability platform systematically screening molecules in early development, pinpointing candidates with optimal potential for progression to Investigational New Drug (IND) and Biological License Application (BLA). With a minimal requirement of 20 milligrams of material, this assessment platform empowers clients to perform a comprehensive risk assessment for unsorted drug candidates in just one month.

Need data on a specific region in this market?
Request Customisation

Antibody Contract Manufacturing Market Merger And Acquisition: Asahi Kasei Medical's Bioprocess Expansion Through Bionova Scientific Acquisition

In April 2022, Asahi Kasei Medical Co. Ltd., a Japan-based pharmaceutical company, acquired Bionova Scientific LLC for an undisclosed amount. This acquisition facilitated the expansion of Asahi Kasei Medical's bioprocess business by adding a biopharmaceutical CDMO (contract development and manufacturing organization). Bionova Scientific LLC is a US-based contract development and manufacturing organization involved in developing and manufacturing recombinant protein products, including antibodies.

Regional Outlook For The Global Antibody Contract Manufacturing Market

North America was the largest region in the antibody contract manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Defines the Antibody Contract Manufacturing Market?

The antibody contract manufacturing market includes revenues earned by entities by providing services such as cell line development, process optimization, and the manufacturing of clinical trial materials. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Antibody Contract Manufacturing Industry?

The antibody contract manufacturing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the antibody contract manufacturing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Antibody Contract Manufacturing Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $16.79 billion
Revenue Forecast In 2034 $29.79 billion
Growth Rate CAGR of 15.4% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Product: Monoclonal Antibodies, Polyclonal Antibodies, Other Products
2) By Source: Mammalian, Microbial
3) Scale Of Operation: Preclinical, Clinical, Commercial
4) By End-User: Biopharmaceutical Companies, Research Laboratories, Other End Users Subsegments: 1) By Monoclonal Antibodies: Therapeutic Monoclonal Antibodies, Diagnostic Monoclonal Antibodies
2) By Polyclonal Antibodies: Research Polyclonal Antibodies, Therapeutic Polyclonal Antibodies
3) By Other Products: Bispecific Antibodies, Antibody-Drug Conjugates (ADCs), Fusion Proteins
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled AbbVie Inc., Thermo Fisher Scientific Inc., Boehringer Ingelheim Biopharmaceuticals GmbH, Fujifilm Holdings Corporation, Eurofins Scientific SE, Lonza Group AG, Labcorp Drug Development, Catalent Inc., Charles River Laboratories International Inc., Merck KGaA, Samsung Biologics Co. Ltd., Wuxi Biologics Cayman Inc, Siegfried Holding AG, Recipharm AB, Emergent BioSolutions Inc., Aenova Group, Cambrex Corporation, Aldevron LLC, Novasep Holding SAS, Synthon, KBI Biopharma Inc., Nitto Avecia Pharma Services Inc., Cytovance Biologics Inc., AGC Biologics S.p.A.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Antibody Contract Manufacturing Market Characteristics

3. Antibody Contract Manufacturing Market Trends And Strategies

4. Antibody Contract Manufacturing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Antibody Contract Manufacturing Growth Analysis And Strategic Analysis Framework

5.1. Global Antibody Contract Manufacturing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Antibody Contract Manufacturing Market Growth Rate Analysis

5.4. Global Antibody Contract Manufacturing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Antibody Contract Manufacturing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Antibody Contract Manufacturing Total Addressable Market (TAM)

6. Antibody Contract Manufacturing Market Segmentation

6.1. Global Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Monoclonal Antibodies

Polyclonal Antibodies

Other Products

6.2. Global Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Mammalian

Microbial

6.3. Global Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Preclinical

Clinical

Commercial

6.4. Global Antibody Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Biopharmaceutical Companies

Research Laboratories

Other End Users

6.5. Global Antibody Contract Manufacturing Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Therapeutic Monoclonal Antibodies

Diagnostic Monoclonal Antibodies

6.6. Global Antibody Contract Manufacturing Market, Sub-Segmentation Of Polyclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Research Polyclonal Antibodies

Therapeutic Polyclonal Antibodies

6.7. Global Antibody Contract Manufacturing Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Bispecific Antibodies

Antibody-Drug Conjugates (ADCs)

Fusion Proteins

7. Antibody Contract Manufacturing Market Regional And Country Analysis

7.1. Global Antibody Contract Manufacturing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Antibody Contract Manufacturing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Antibody Contract Manufacturing Market

8.1. Asia-Pacific Antibody Contract Manufacturing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Antibody Contract Manufacturing Market

9.1. China Antibody Contract Manufacturing Market Overview

9.2. China Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Antibody Contract Manufacturing Market

10.1. India Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Antibody Contract Manufacturing Market

11.1. Japan Antibody Contract Manufacturing Market Overview

11.2. Japan Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Antibody Contract Manufacturing Market

12.1. Australia Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Antibody Contract Manufacturing Market

13.1. Indonesia Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Antibody Contract Manufacturing Market

14.1. South Korea Antibody Contract Manufacturing Market Overview

14.2. South Korea Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Antibody Contract Manufacturing Market

15.1. Western Europe Antibody Contract Manufacturing Market Overview

15.2. Western Europe Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Antibody Contract Manufacturing Market

16.1. UK Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Antibody Contract Manufacturing Market

17.1. Germany Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Antibody Contract Manufacturing Market

18.1. France Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Antibody Contract Manufacturing Market

19.1. Italy Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Antibody Contract Manufacturing Market

20.1. Spain Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Antibody Contract Manufacturing Market

21.1. Eastern Europe Antibody Contract Manufacturing Market Overview

21.2. Eastern Europe Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Antibody Contract Manufacturing Market

22.1. Russia Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Antibody Contract Manufacturing Market

23.1. North America Antibody Contract Manufacturing Market Overview

23.2. North America Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Antibody Contract Manufacturing Market

24.1. USA Antibody Contract Manufacturing Market Overview

24.2. USA Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Antibody Contract Manufacturing Market

25.1. Canada Antibody Contract Manufacturing Market Overview

25.2. Canada Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Antibody Contract Manufacturing Market

26.1. South America Antibody Contract Manufacturing Market Overview

26.2. South America Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Antibody Contract Manufacturing Market

27.1. Brazil Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Antibody Contract Manufacturing Market

28.1. Middle East Antibody Contract Manufacturing Market Overview

28.2. Middle East Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Antibody Contract Manufacturing Market

29.1. Africa Antibody Contract Manufacturing Market Overview

29.2. Africa Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Antibody Contract Manufacturing Market Competitive Landscape And Company Profiles

30.1. Antibody Contract Manufacturing Market Competitive Landscape

30.2. Antibody Contract Manufacturing Market Company Profiles

30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Boehringer Ingelheim Biopharmaceuticals GmbH Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Fujifilm Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

31. Antibody Contract Manufacturing Market Other Major And Innovative Companies

31.1. Lonza Group AG

31.2. Labcorp Drug Development

31.3. Catalent Inc.

31.4. Charles River Laboratories International Inc.

31.5. Merck KGaA

31.6. Samsung Biologics Co. Ltd.

31.7. Wuxi Biologics Cayman Inc

31.8. Siegfried Holding AG

31.9. Recipharm AB

31.10. Emergent BioSolutions Inc.

31.11. Aenova Group

31.12. Cambrex Corporation

31.13. Aldevron LLC

31.14. Novasep Holding SAS

31.15. Synthon

32. Global Antibody Contract Manufacturing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Antibody Contract Manufacturing Market

34. Recent Developments In The Antibody Contract Manufacturing Market

35. Antibody Contract Manufacturing Market High Potential Countries, Segments and Strategies

35.1 Antibody Contract Manufacturing Market In 2029 - Countries Offering Most New Opportunities

35.2 Antibody Contract Manufacturing Market In 2029 - Segments Offering Most New Opportunities

35.3 Antibody Contract Manufacturing Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Antibody Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Antibody Contract Manufacturing Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Antibody Contract Manufacturing Market, Sub-Segmentation Of Polyclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Antibody Contract Manufacturing Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Antibody Contract Manufacturing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Antibody Contract Manufacturing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: AbbVie Inc. Financial Performance
  • Table 79: Thermo Fisher Scientific Inc. Financial Performance
  • Table 80: Boehringer Ingelheim Biopharmaceuticals GmbH Financial Performance
  • Table 81: Fujifilm Holdings Corporation Financial Performance
  • Table 82: Eurofins Scientific SE Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Antibody Contract Manufacturing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Antibody Contract Manufacturing Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Antibody Contract Manufacturing Market, Sub-Segmentation Of Polyclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Antibody Contract Manufacturing Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Antibody Contract Manufacturing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Antibody Contract Manufacturing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Antibody Contract Manufacturing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Antibody Contract Manufacturing Market, Segmentation By Source, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Antibody Contract Manufacturing Market, Segmentation By Scale Of Operation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: AbbVie Inc. Financial Performance
  • Figure 79: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 80: Boehringer Ingelheim Biopharmaceuticals GmbH Financial Performance
  • Figure 81: Fujifilm Holdings Corporation Financial Performance
  • Figure 82: Eurofins Scientific SE Financial Performance

$5.62 Billion Forecast for Liver Cancer Market by 2029, Backed by Demand and Innovation

Read More About $5.62 Billion Forecast for Liver Cancer Market by 2029, Backed by Demand and Innovation

Lupus Nephritis Market Valuation Expected To Reach $2.78 Billion By 2029, Growing At A Rate Of 7.5%

Read More About Lupus Nephritis Market Valuation Expected To Reach $2.78 Billion By 2029, Growing At A Rate Of 7.5%

Strong CAGR to Propel in the Malignant Mesothelioma Market and Beyond upto $3.32 Billion by 2029

Read More About Strong CAGR to Propel in the Malignant Mesothelioma Market and Beyond upto $3.32 Billion by 2029

Malignant Pleural Effusion Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

Read More About Malignant Pleural Effusion Market in Focus: Forecasting Growth Drivers, Scaling Potential, and Global Opportunities

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Bearing Steel Global Market Report 2025 - By Product Type (High Carbon Chromium, Carburizing, High Temperature, Other Products), By Application (Ball Bearings, Roller Bearings, Thrust Bearings, Plain Bearings, Other Appl...

View Report

Genu Recurvatum Global Market Report 2025 – By Type (External Rotatory Deformity (ERD), Internal Rotatory Deformity (IRD), Non-Rotatory Deformity (NRD)), By Diagnosis (Magnetic Resonance Imaging (MRI), X-Rays, Other Diag...

View Report

Neuromorphic Chips Global Market Report 2025 – By Components (Software, Hardware), By Function (Signal Processing, Data Processing, Image Recognition, Process optimization), By End Use Industry (Aerospace And Defense, Au...

View Report

Research Antibodies and Reagents Global Market Report 2025 – By Technology (Western Blot, Immunofluorescence, Immunohistochemistry, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (Elisa), Others), By Application (Prot...

View Report

Refrigerated Display Cabinets Global Market Report 2025 – By Type (Frozen Type, Chilled Type ), By Application (Beverages, Food, Medicine, Other Applications ), By End-Users (Supermarkets, Convenience Stores) – Impact of...

View Report

Polyphenylene Global Market Report 2025 – By Type( Polyphenylene Sulfide(PPS), Polyphenylene Ether/Oxide(PPE/PPO), Other Types ), By Application( Composites, Engineering Plastics, High Performance Lubricants, Filter Bags...

View Report

Baby Powder Global Market Report 2025 – By Product (Talc-Based, Talc-Free), By Distribution Channel (Online, Offline), By End User (Infant, Toddler) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Fo...

View Report

Frequently Asked Questions

Antibody contract manufacturing refers to outsourcing the production and manufacturing of antibodies to specialized contract manufacturing organizations (CMOs). These CMOs are equipped with the expertise, infrastructure, and resources necessary to manufacture antibodies on behalf of pharmaceutical and biotechnology companies. For further insights on this market, request a sample here

The market major growth driver - Surge In Clinical Trials Fuels The Antibody Contract Manufacturing Market Growth. For further insights on this market, request a sample here

The antibody contract manufacturing market size has grown rapidly in recent years. It will grow from $14.8 billion in 2024 to $16.79 billion in 2025 at a compound annual growth rate (CAGR) of 13.4%. The growth in the historic period can be attributed to increased demand for monoclonal antibodies, shift towards personalized medicine, cost optimization, stringent regulatory requirements, globalization of biologics. The antibody contract manufacturing market size is expected to see rapid growth in the next few years. It will grow to " $29.79 billion in 2029 at a compound annual growth rate (CAGR) of 15.4%. The growth in the forecast period can be attributed to increasing r&d spending, expansion of bispecific and multispecific antibodies, rise of antibody-drug conjugates (adcs), increasing healthcare infrastructure, growing government initiatives. Major trends in the forecast period include digitalization and data analytics, advanced upstream technologies, novel downstream processing techniques, sustainability initiatives, contract development and manufacturing integration (CDMO). For further insights on this market, request a sample here

The antibody contract manufacturingmarket covered in this report is segmented –
1) By Product: Monoclonal Antibodies; Polyclonal Antibodies; Other Products
2) By Source: Mammalian; Microbial
3) Scale Of Operation: Preclinical; Clinical; Commercial
4) By End-User: Biopharmaceutical Companies; Research Laboratories; Other End Users Subsegments:
1) By Monoclonal Antibodies: Therapeutic Monoclonal Antibodies; Diagnostic Monoclonal Antibodies
2) By Polyclonal Antibodies: Research Polyclonal Antibodies; Therapeutic Polyclonal Antibodies
3) By Other Products: Bispecific Antibodies; Antibody-Drug Conjugates (ADCs); Fusion Proteins For further insights on this market, request a sample here

North America was the largest region in the antibody contract manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antibody contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the antibody contract manufacturing market include AbbVie Inc., Thermo Fisher Scientific Inc., Boehringer Ingelheim Biopharmaceuticals GmbH, Fujifilm Holdings Corporation, Eurofins Scientific SE, Lonza Group AG, Labcorp Drug Development, Catalent Inc., Charles River Laboratories International Inc., Merck KGaA, Samsung Biologics Co. Ltd., Wuxi Biologics Cayman Inc, Siegfried Holding AG, Recipharm AB, Emergent BioSolutions Inc., Aenova Group, Cambrex Corporation, Aldevron LLC, Novasep Holding SAS, Synthon, KBI Biopharma Inc., Nitto Avecia Pharma Services Inc., Cytovance Biologics Inc., AGC Biologics S.p.A. . For further insights on this market, request a sample here.

Major trends in this market include Innovative Single-Use Technology Enhances Antibody-Drug Conjugate Manufacturing Efficiency. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Antibody Contract Manufacturing Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon